Reimbursement and payment models in Central and Eastern European as well as Middle Eastern countries: A survey of their current use and future outlook

Publication date

2023-01-01

Authors

Callenbach, Marcelien Heidrun ElisabethISNI 000000051251054X
Ádám, Lldikó
Vreman, R AISNI 0000000492512512
Németh, Bertalan
Kaló, Zoltán
Goettsch, WimORCID 0000-0002-8022-7496ISNI 0000000395155859

Editors

Advisors

Supervisors

Document Type

Article
Open Access logo

License

cc_by

Abstract

There is growing interest in innovative reimbursement and payment models in Central and Eastern European (CEE) and Middle Eastern (ME) countries. A questionnaire was sent to payers from CEE and ME countries regarding the current use of, future preferences for and perceived barriers with these models. Twenty-seven healthcare payers from 11 countries completed the survey. Results showed participants preferred using outcome-based reimbursement models and delayed payment models more often; however, currently they are rarely applied. Barriers hindering implementation were mostly related to IT and data infrastructure, measurement issues, transaction costs and the administrative burden. Given these barriers highlighted in our study, policymakers should focus on the development of an implementation framework with contract templates for the preferred reimbursement and payment schemes to aid the feasibility of a successful implementation.

Keywords

Central and Eastern Europe, Delayed payment, Managed entry agreements, Middle East, Outcome-based reimbursement, Pharmaceutical reimbursement

Citation

Callenbach, M H E, Ádám, L, Vreman, R A, Németh, B, Kaló, Z & Goettsch, W G 2023, 'Reimbursement and payment models in Central and Eastern European as well as Middle Eastern countries : A survey of their current use and future outlook', Drug Discovery Today, vol. 28, no. 1, 103433, pp. 1-9. https://doi.org/10.1016/j.drudis.2022.103433